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Abstract
Background: Ageing populations will impact on healthcare provision, especially since extra years
are not necessarily spent in good health. It is important to identify and understand the significance
of common medical problems in older people. Anaemia may be one such problem. We report on
the prevalence of anaemia in cohorts of elderly people in the general population. The presence of
anaemia is associated with a worse prognosis for both morbidity and mortality.
Methods: Electronic searching and reference lists of published reports were used to identify
studies that reported on prevalence of anaemia in cohorts of at least 100 individuals predominantly
aged 65 years and over living in developed countries, together with criteria used to define anaemia.
Studies of anaemia prevalence in specific disease groups or published before 1980 were excluded.
Prevalence data for the entire cohort, for men and women separately and for different age bands
were extracted.
Results: Forty-five studies contributed data. Thirty-four studies (n = 85,409) used WHO criteria
to define anaemia. The weighted mean prevalence was 17% (3–50%) overall, and 12% (3–25%) in
studies based in the community (27, n = 69,975), 47% (31–50%) in nursing homes (3, n = 1481),
and 40% (40–72%) in hospital admissions (4, n = 13,953). Anaemia prevalence increased with age,
was slightly higher in men than women, and was higher in black people than white. Most individuals
classified as anaemic using WHO criteria were only mildly anaemic.
Conclusion: Anaemia, as defined by WHO criteria, is common in older people living in the
community and particularly common in nursing home residents and hospital admissions. Predicted
demographic changes underline the need to understand more about anaemia in older people.
Background
The world population is ageing; in 2000 there were 600
million people aged 60 or over, and it is estimated that
this figure will double by 2025, and more than triple to 2
billion by 2050 [1]. Between 2007 and 2027 the number
of people aged 65 years or older in England alone is pre-
dicted to increase by 200,000 each year, rising from eight
to 12 million over that 20-year period [2]. In the USA
numbers aged 65 years or older are predicted to rise from
37 million in 2006 to 63 million by 2025 [3].
The "oldest old", often defined as those aged 85 or older,
show the largest increase in numbers. By 2066 it is antici-
pated that there will be almost a third of a million people
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aged 100 years or older, in a population of 70 million in
the UK [2]. In the USA the prediction is for a third of a mil-
lion over the age of 100 years by 2020 [3].
This demographic change has obvious implications for
individuals and society. It will impact particularly on
healthcare provision, especially as longer life does not
necessarily mean more years enjoyed in good health. It
becomes increasingly important to highlight common
medical problems in older people, especially if their
extent and potential significance are not generally recog-
nised. We suspected that anaemia might be one such
problem.
Anaemia is often defined in terms of the WHO criteria,
established in 1968 [4]. The WHO definition of anaemia
is a haemoglobin (Hb) concentration <130 g/L in men,
and <120 g/L in women. There has been debate about the
use of these values [5], and in particular, whether they
should be used to define anaemia in older people [6], but
there is no widely accepted alternative definition of anae-
mia in this age group.
In general, haemoglobin levels are lower in older than in
younger people. The reasons for this are not completely
understood. It is unclear whether haemoglobin falls in
older people because this is a feature of normal ageing, or
whether it is always pathological, even if underlying con-
ditions cannot be identified. In an individual patient it
may be that some decline in haemoglobin occurs as part
of normal ageing, but that disease may also contribute to
the development of anaemia.
Anaemia of chronic disease, or anaemia of chronic
inflammation, is the term associated with some chronic
medical conditions, such as chronic renal disease and
rheumatoid arthritis. Older people who suffer such
chronic conditions might be expected to be anaemic, just
as younger patients are. However, it is not always appreci-
ated that older patients who suffer other medical prob-
lems, for example cognitive impairment, have a worse
prognosis if they are also anaemic. It is not surprising that
anaemia is associated with heart failure or myocardial inf-
arction or death, but the reasons underlying the associa-
tion between anaemia and other morbidity are less
tangible.
We report on the prevalence of anaemia in cohorts of
older people in the general population.
Methods
MEDLINE and EMBASE (Ovid interface) were searched
for the years 1980 to February 2007 for studies reporting
prevalence of anaemia in elderly populations or cohorts,
using search strategies described in Additional file 1. It is
known that observational studies can be difficult to iden-
tify through electronic searching [7,8], so reference lists of
retrieved studies and reviews were also searched carefully
for further reports, together with "linked articles" in
PubMed. Full reports were obtained whenever possible
for all studies identified from their abstracts as potentially
useful.
Studies were included if they reported prevalence of anae-
mia for cohorts of at least 100 individuals aged predomi-
nantly 65 and over living in developed countries, together
with the criteria used to define anaemia. Studies of anae-
mia prevalence in specific disease groups (diabetes, rheu-
matoid arthritis, renal disease) or in "extreme"
populations (extreme poverty, poor nutrition) were
excluded. Where more than one paper reported on the
same or overlapping cohorts, or subgroups of large
cohorts, care was taken to avoid double counting, and the
report with the most information on the largest number
of individuals was used. We limited the search to studies
published since 1980 to avoid possible historical changes
in prevalence, which might be due to improvements in
diet and general health.
For each report we extracted information on the country
of residence, how the cohort was selected (for instance,
random sampling, inclusive cohort) and whether individ-
uals were living in the community, in nursing homes or
were hospitalised, together with numbers studied, sex,
mean age, criteria used to define anaemia, comorbidities
and specific inclusion or exclusion criteria. For anaemia
we sought details of overall prevalence, prevalence by age
group, and prevalence in men and women separately.
Where associations were found between anaemia and par-
ticular outcomes (mortality, cognitive function, disabil-
ity) or medication use, these were also noted.
Two authors (HG, SD) carried out searching, study selec-
tion, and data extraction independently and disagree-
ments were resolved by consensus (RAM, HG, SD).
It was recognised that the studies would be heterogeneous
both in terms of the cohorts and the criteria used to define
anaemia, so that any planned analysis should be simple
and in large part qualitative. We did plan to calculate a
weighted mean prevalence using the most commonly
used definition of anaemia both overall, and for men and
women separately. Sensitivity analyses were planned for
community-living versus institutionalised (nursing
home) or patients admitted to hospital, and for older
(1980–1999) versus recent (2000–2006) studies. The
weighted mean was calculated by dividing the sum of the
product of prevalence (as percentage) and number of
patients by the sum of the number of patients.BMC Geriatrics 2008, 8:1 http://www.biomedcentral.com/1471-2318/8/1
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Results
Electronic searches identified a total of 293 and 153 arti-
cles in Medline and EMBASE respectively, and many more
from bibliographies of retrieved papers or "linked arti-
cles" in PubMed. A total of 83 studies were reviewed in
detail, and 45 [9-53] were included, with details in Addi-
tional file 2. For two included studies [35,40] the full
paper was not available, but adequate details were given
in the abstract, and another [25] was published as a letter
rather than a full report. A list of excluded studies, with
reason for exclusion, is in Additional file 3.
Most studies were of moderate size. The distribution of
the 35 studies using WHO criteria of anaemia by size is
shown in Table 1. Only two examined at least 10,000
individuals ([13,16] Table 1), and the five studies with at
least 5,000 individuals contributed over 60% of the total
number of individuals. Twenty-six studies (76% of the
total studies) examined fewer than 2,500 individuals
(25% of total individuals). Almost half the 35 studies had
fewer than 1,000 individuals, and contributed less than
8% of the total.
The majority (34/45, 76%) of studies were of individuals
living independently in the community, although a few
included some individuals in nursing homes or hospital.
Four studies [17,22,23,40] were in nursing homes and
seven studies [12,14,16,25,30,37,41] assessed patients
who had been admitted to hospital.
The WHO criteria of Hb < 130 g/L for men and <120 g/L
for women was by far the most commonly used to define
anaemia, though we did accept results from three studies
[15,19,43] that used thresholds within 5 g/L of these.
Other criteria included Hb < 140 g/L for men and 120 g/L
for women, Hb levels of <120 to <80 g/L for both sexes, or
various percentiles of the cohort. Haematocrit (Hct) levels
are sometimes used to define anaemia. For example Hct
39% for men and 36% for women are alternative WHO
criteria for defining anaemia [4], and two studies using
Hct were included in the analysis of studies using WHO
criteria (± 1%) [29,52]. Where studies used a much lower
concentration of haemoglobin to define anaemia, for
instance <120 g/L or <110 g/L, we also extracted the prev-
alence information for these lower levels.
Thirty-four studies, with 85,409 individuals, using WHO
criteria, yielded a weighted mean anaemia prevalence of
17% (range 3% to 50%). The weighted mean prevalence
was 12% (3% to 26%) in 27 studies predominantly in the
community (69,975 individuals), 47% (31% to 50%) in
three studies in nursing homes (1481 individuals
[17,22,53]) and 40% (40% to 72%) in four studies in hos-
pital admissions (13,953 individuals [12,14,16,25]; Table
2). Figure 1 shows the distribution of anaemia prevalence
according to population (community, nursing home, and
hospital admission) and cohort size. Anaemia was more
prevalent in nursing homes or hospital admissions than
in the community, and there was no overlap in anaemia
prevalence between these groups (Figure 1).
Two studies in the community (2341 individuals)
[39,51], and one in a nursing home (175 individuals)
[40] defined anaemia as Hb ≤ 120 g/L, giving prevalence
rates of 7%, 11% (weighted mean 8%) and 24% respec-
tively. A further three studies (21,170 individuals)
[35,51,10] in the community and one in a nursing home
(441 individuals) [17] used Hb ≤ 110 g/L, giving preva-
lence rates of 3%, 13%, 3% (weighted mean 6%) and 25%
respectively. Generally, prevalence fell rapidly with lower
thresholds, indicating that the vast majority of individuals
classified as anaemic using WHO criteria were in fact only
mildly anaemic.
Sensitivity analyses (Table 2) examining the effect of pub-
lication date in the community or nursing home studies
found similar prevalence in those published before 2000
(15%) and since 2000 (12%). Prevalence was slightly
higher in men (15%) than women (14%) in studies
reporting by sex. The two studies using Hct to define anae-
mia contributed less than 3% of the total population in
community studies and excluding them did not alter the
weighted mean estimate. Eight studies reported anaemia
prevalence in different age groups, and there was a clear
increase in prevalence with age (Figure 2). Other studies
reported an increase in prevalence with age, but without
giving the numbers.
Five studies commented on prevalence of anaemia and
ethnicity [52,11,21,24,42]. All indicated that anaemia
prevalence was higher in black populations than white
and Mexican-Americans, by a factor of about three times.
Discussion
These results confirm that anaemia, as defined by the
WHO criteria, is common in older people, affecting 1 in
every 7 or 8 over-65s living in the community. Even using
Table 1: Studies reporting anaemia in older persons using WHO 
criteria
Number of Percent of total
Size range 
(individuals)
Studies Patients Studies Patients
10,000–20,000 2 30,331 5.9 35.5
5,000–10,000 3 21,590 8.8 25.3
2,500–5,000 3 12,373 8.8 14.5
1,000–2,500 10 14,867 29.4 17.4
100–1,000 16 6,248 47.1 7.3BMC Geriatrics 2008, 8:1 http://www.biomedcentral.com/1471-2318/8/1
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more stringent definitions of haemoglobin less than 120
g/L or 110 g/L, anaemia affects 1 in 12 to 1 in 15 older
people in the community. In nursing homes, or in older
people admitted to hospital, anaemia will be even more
common, affecting almost 1 in 2. Higher prevalence
occurs at greater age, and in black people.
These broad assertions have limitations. Firstly we have
chosen to use the WHO criteria for defining anaemia
because they are the most commonly reported. Threshold
values are to some extent arbitrary, and WHO values are
in the range of haemoglobin levels where the number of
individuals captured changes rapidly. Choosing slightly
Anaemia prevalence by age range Figure 2
Anaemia prevalence by age range. Size of the symbol is pro-
portional to the size of the cohort (inset scale)
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Table 2: Summary of results, including sensitivity analyses and use of alternative criteria for anaemia
Number of studies Number of individuals Anaemia (weighted mean %)
WHO criteria
All studies 34 85409 17
Community/Nursing Home 31 71456 13
Community only 27 69975 12
Nursing Homes only 4 1481 47
Hospital admissions only 3 13953 40
Sensitivity analyses
Community/Nursing Home before 2000 12 19708 15
Community/Nursing Home 2000 and later 18 51748 12
Men 26 23856 15
Women 28 35781 14
Community only using Hb only 26 68912 12
Alternative criteria
Community/Nursing Home Hb ≤ 120 g/L 3 2516 9
Community/Nursing Home Hb ≤ 110 g/L 4 21611 6
Note: Individual studies were weighted by number of individuals for calculation of overall mean rate of anaemia
Anaemia prevalence according to the size of cohort (non-lin- ear inset scale) Figure 1
Anaemia prevalence according to the size of cohort (non-lin-
ear inset scale). Yellow symbols represent older people living 
in the community, blue those in nursing homes, and red 
admission to hospital.
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different thresholds can considerably alter the number
defined as anaemic. While we recognise the limitations of
using thresholds, we have used WHO criteria because that
is what is reported in the literature and because they do
appear to be relevant, correlating with clinical outcomes.
We know, furthermore, that electronic searching for
observational studies identifies fewer than half of studies,
so that other methods have to be employed [7,8]. While
we examined bibliographies extensively, it is likely that
some information was not identified by our searches.
Though we limited our inclusion criteria to studies with at
least 100 individuals, Table 1 demonstrates that small
studies contributed little to the overall numbers, which
were dominated by five studies of more than 5,000 indi-
viduals. Overall there was information on prevalence for
almost 86,000 individuals, over 60% of whom were in
these large studies. This justifies excluding prevalence
studies with fewer than 100 subjects; non-inclusion of
even 100 trials with fewer than 100 subjects would have
contributed a maximum of 10% more to the total, and we
found that 50% of the studies included with the smallest
numbers actually contributed 8% to the total.
Only 34 of 45 studies used the WHO criteria of anaemia
established in 1968 [4]. With highly variable definitions
and prevalence clearly influenced by definition, we con-
centrated on the studies using the WHO definition. Addi-
tionally we arbitrarily imposed a 1980 cut off for
publications to restrict influences from very different
times from today. A sensitivity analysis comparing studies
published between 1980 and 2000 and those after 2000
did not show any large temporal variation, though (Table
2).
Even the studies we accessed did not all have the determi-
nation of anaemia prevalence in older people as their
prime outcome. Rather, they were studies of association of
anaemia with morbidity or disease, or examined anaemia
as only one element of the study. Moreover, there were
very limited amounts of information on important sub-
groups, like the oldest old, those with comorbities, or
with ethnic or cultural differences. Information might be
indicative, but it is difficult to have confidence in the pre-
cision of estimates in subgroups with such small num-
bers. More detailed studies can help, as with a recent study
on racial variation and anaemia mortality and morbidity
[54].
A degree of heterogeneity in the cohort studies was
expected, and was found. We chose a crude separation
between individuals living in the community, in nursing
homes, or admitted to hospital as obvious differences
between individuals, but within each cohort different dis-
tributions of age, ethnicity, and conditions would apply.
Few studies tried, for instance, to give a population-based
assessment by sampling according to a population norm.
Sampling methods varied greatly. Some cohorts were
inclusive, while others used random sampling, sometimes
stratified, or with deliberate over-sampling of minority
groups (ethnic, older old), and others did not specify
methods.
Two very large studies could not be included because they
did not define anaemia. The larger reported on over 1.1
million individuals in a general Medicare database [55],
and reported patients with ICD-9-CM coding of anaemia
rather than any particular threshold of haemoglobin or
haematocrit. The diagnosis of anaemia was made in 15%
of individuals, with a mean age of 77 years. Another large
study of 43,510 nursing home residents reported 19%
prevalence of anaemia, but without stating the criteria
used [56]. Both were largely in line with the results of this
review.
Another very large study of 91,000 patients with recent
myocardial infarction could not be included because it
used Hct of ≤ 39% as the threshold for anaemia in both
men and women [57]. This study did give a breakdown by
different haematocrit bands and sex, but reported a
denominator from which individuals with high haemat-
ocrit values were excluded. Adding back these individuals,
and assuming the same sex distribution amongst them as
in the next highest band, gave an overall prevalence of
26% (28% in men, 25% in women). This is lower than the
included studies of hospital admissions, but is difficult to
interpret because of the clinical characteristics of the
patients and the assumptions that had to be made to cal-
culate prevalence.
A previous systematic review [58] included 71 studies on
patients aged 60 years or older, but limited analysis to
effects of sex differences reported in nine studies, and age
differences reported in six studies. This new review used
searches conduced about six years later, with wider inclu-
sion criteria (such as abstracts), but more stringent criteria
(such as definition of anaemia using WHO criteria, and
exclusion of small studies). A consequence was that we
reviewed a smaller number of studies, probably of higher
quality, and examined issues not examined previously,
such as the link between setting and anaemia prevalence.
The previous review concluded that anaemia prevalence
was generally higher in men than women. We found only
a small difference, but confined our comparison to studies
using the same WHO criteria for anaemia, whereas Beghe
et al [58] included studies using different definitions,
including thresholds for men ranging from 110 g/L to 140
g/L. The finding of increasing prevalence with older age
was confirmed in our analysis, though with more studiesBMC Geriatrics 2008, 8:1 http://www.biomedcentral.com/1471-2318/8/1
Page 6 of 8
(page number not for citation purposes)
(Figure 2); we did not include one small report of anae-
mia prevalence of 53% in 89 centenarians [59]. This
review, limited to persons aged 65 years and older, and to
studies of at least 100 patients, additionally points to dif-
ferences in anaemia prevalence between older people liv-
ing in the community, in nursing homes, or admitted to
hospital. The previous review [58] also noted the difficul-
ties in drawing meaningful conclusions from disparate
studies, and while we did extract potentially useful infor-
mation from the studies (Additional file 2), we felt that
clinical and methodological heterogeneity, and disparities
in size, were too great to attempt further sensitivity analy-
sis.
The rapid fall in prevalence of anaemia with definitions
using lower thresholds (such as 110 g/L) suggests that in
most cases the anaemia is mild. Despite this, the presence
of anaemia in older people is associated with poorer out-
comes. Older people (mean age 77 years) with anaemia
suffered higher mortality (57%) than those without anae-
mia (39%) when followed up for almost 12 years [21].
Both anaemia and renal insufficiency appear to be inde-
pendent risk factors for death among patients with heart
failure [59] and after myocardial infarction [60], and
anaemia predicts mortality in severe heart failure [61,62].
Anaemia is also associated with increased risk of falls and
impaired muscle strength [63], executive function impair-
ment [64] and dementia [65], hospital admission [66],
and longer hospital stay [50,66].
Knowing the prevalence of anaemia in older people is
important because we can begin to estimate the extent of
the problem in this group. In the UK in 2007 there are
almost 10 million people aged 65 years or older; the
implication is that 1.5 million have anaemia as defined by
WHO, and perhaps 600,000 have haemoglobin levels
below 110 g/L. In thirty years there will probably be half
as many again.
Studies have consistently demonstrated an approximately
three times higher prevalence in black people between
black and white people [5,67] of all ages, not confined to
the elderly, though differences narrowed when iron-defi-
cient or thalassaemic patients were excluded [67]. While
the reasons and consequences may be uncertain, and this
is an area of some controversy, the use of different diag-
nostic criteria is not, so far, suggested, though attempts
have been made to do so [5]. The literature we reviewed
provided little information about the prevalence and con-
sequences of the racial differences in anaemia. As has been
pointed out [5], the genes of individuals classified as Afri-
can-American could be anywhere between 10% and 90%
of European origin. There is, in addition, a gradient in
haemoglobin concentrations between whites of northern
versus southern European ancestry [5]. This is clearly not
a simple topic.
The similar prevalence found in studies published before
and after 2000 suggests that significant advances in iden-
tifying and/or treating anaemia in older people have not
been made in recent years. It is estimated that for between
14% and 50% of cases of anaemia in the elderly, the
underlying cause is unexplained [24,57]. We know little
about whether it is preventable, or how much is associ-
ated with medications for other medical conditions of
older age, except for NSAIDs [68] and perhaps low dose
aspirin [13]. There does not appear to be an extensive lit-
erature on therapy, and whether therapy improves quality
of life and outcomes in older people.
We, as others before [58], find the limitations of the liter-
ature, especially the small number of larger studies in
defined communities with defined criteria, limit any
methodological considerations without the danger of
over analysis. To some extent the unanswered questions
are more interesting than those that can be answered – for
example about the causes, health and economic conse-
quences, and treatment of anaemia in older people, and
the desirability or otherwise of using different action lev-
els than the WHO definitions of anaemia. While the usual
call for more research is often rather lame, in this case the
extraordinary expected growth in the numbers of older
people, coupled with the high prevalence and potentially
serious consequences of anaemia, suggest that in this case
more research is a sensible conclusion.
Conclusion
Anaemia as defined using WHO criteria is common in
older people living in the community, and is higher in the
older old and black people. It is particularly common
amongst nursing home residents and older people admit-
ted to hospital. The presence of anaemia is associated with
a worse prognosis, with increases in morbidity and mor-
tality. Predicted demographic changes will increase the
burden and underline the need to understand more about
anaemia in older people.
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